BRIEF-Mateon Therapeutics Inc Says First Patient Enrolled This Week In Its Phase IV Study
BRIEF-Mateon Therapeutics Inc Says First Patient Enrolled This Week In Its Phase IV Study
Brief-Mateon治疗公司表示,本周第一名患者登记参加其IV期研究
Oct 7 (Reuters) - Mateon Therapeutics Inc MATN.PK :
路透10月7日电-Mateon治疗公司MATN.PK:
* MATEON THERAPEUTICS INC - ANNOUNCED FIRST PATIENT ENROLLED THIS WEEK IN ITS PHASE IV STUDY ARTI-19
*MATEON治疗公司-本周宣布第一名患者参加其第四阶段研究ARTI-19
* MATEON THERAPEUTICS INC - TOP-LINE DATA FROM ARTI-19 IS EXPECTED BY END OF 4Q20
*MATEON治疗公司-ARTI-19的一线数据预计将在20年第四季度末公布
Source text for Eikon: Further company coverage:
Eikon的源文本:进一步的公司报道: